These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

63 related items for PubMed ID: 9403092

  • 21. Gender-specific effects in the treatment of acute schizophrenia with risperidone.
    Raedler TJ, Schreiner A, Naber D, Wiedemann K.
    Pharmacopsychiatry; 2006 Sep; 39(5):171-4. PubMed ID: 16944407
    [Abstract] [Full Text] [Related]

  • 22. Evaluation of the clinical efficacy of risperidone for untreated and treated cases of schizophrenia from various aspects.
    Himei A, Okamura T.
    Psychiatry Clin Neurosci; 2005 Oct; 59(5):556-62. PubMed ID: 16194258
    [Abstract] [Full Text] [Related]

  • 23. Adjunctive treatment with risperidone in clozapine-resistant schizophrenia: a case report and review.
    Lerma-Carrillo I, Molina JD, Cuevas-Durán T, González-Parra S, Blasco-Fontecilla H, Andrade-Rosa C, López-Muñoz F, Alamo C.
    Clin Neuropharmacol; 2007 Oct; 30(2):114-21. PubMed ID: 17414944
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Randomized clinical comparison of perospirone and risperidone in patients with schizophrenia: Kansai Psychiatric Multicenter Study.
    Okugawa G, Kato M, Wakeno M, Koh J, Morikawa M, Matsumoto N, Shinosaki K, Yoneda H, Kishimoto T, Kinoshita T.
    Psychiatry Clin Neurosci; 2009 Jun; 63(3):322-8. PubMed ID: 19566763
    [Abstract] [Full Text] [Related]

  • 26. Risperidone in disorganised schizophrenia.
    Bleich S, Degner D, Kropp S, Hajak G, Rüther E.
    Aust N Z J Psychiatry; 2000 Jun; 34(3):534-5. PubMed ID: 10881990
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Systemic Inflammation Complicates the Interpretation of Therapeutic Drug Monitoring of Risperidone.
    Helland A, Habib S, Ulvestad L, Spigset O.
    J Clin Psychopharmacol; 2018 Jun; 38(3):263-265. PubMed ID: 29613864
    [No Abstract] [Full Text] [Related]

  • 32. Multiple visits for abdominal pain, constipation, and "I need a test for sexually transmitted diseases".
    Rohr-Kirchgraber T.
    Adolesc Med State Art Rev; 2012 Aug; 23(2):313-8. PubMed ID: 23162938
    [No Abstract] [Full Text] [Related]

  • 33. Precompetitive consortium approach to validation of the next generation of biomarkers in schizophrenia.
    Dourish CT, Dawson GR.
    Biomark Med; 2014 Aug; 8(1):5-8. PubMed ID: 24325219
    [No Abstract] [Full Text] [Related]

  • 34. Risperidone for treatment of childhood schizophrenia.
    Sourander A.
    Am J Psychiatry; 1997 Oct; 154(10):1476. PubMed ID: 9326842
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Schizophrenia in the 21st century: new insights and translation into improved therapies.
    Pratt J.
    J Psychopharmacol; 2015 Feb; 29(2):83-4. PubMed ID: 25650373
    [No Abstract] [Full Text] [Related]

  • 40. [3 years of clinical experience with risperidone: new therapeutic standards in the management of schizophrenia].
    Nervenarzt; 1996 Oct; 67(10 Suppl Neue Thera):1-4. PubMed ID: 9403092
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.